SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-08-023427
Filing Date
2008-04-09
Accepted
2008-04-09 14:27:53
Documents
1
Group Members
ALGER ASSOCIATES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a08-10427_5sc13ga.htm SC 13G/A 68141
  Complete submission text file 0001104659-08-023427.txt   70148
Mailing Address 111 FIFTH AVENUE NEW YORK NY 10003
Business Address 111 FIFTH AVENUE 2ND FLOOR NEW YORK NY 10003 212-806-8800
ALGER FRED MANAGEMENT INC (Filed by) CIK: 0000003520 (see all company filings)

IRS No.: 132510833 | Fiscal Year End: 1031
Type: SC 13G/A

Mailing Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Business Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111 (212) 887-6500
Omrix Biopharmaceuticals, Inc. (Subject) CIK: 0001349426 (see all company filings)

IRS No.: 522147005 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82558 | Film No.: 08747401
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1